Literature DB >> 17400022

Peroxisome proliferator-activated receptors (PPARs) in skin health, repair and disease.

Liliane Michalik1, Walter Wahli.   

Abstract

Peroxisome proliferator-activated receptors, PPARalpha, PPARbeta/delta and PPARgamma, are fatty acid activated transcription factors that belong to the nuclear hormone receptor family. While they are best known as transcriptional regulators of lipid and glucose metabolism, evidence has also accumulated for their importance in skin homeostasis. The three PPAR isotypes are expressed in rodent and human skin. Various cell culture and in vivo approaches suggest that PPARalpha contributes to fetal skin development, to epidermal barrier maturation and to sebocyte activity. PPARbeta/delta regulates sebocyte differentiation, promotes hair follicle growth and has pro-differentiating effects in keratinocytes in normal and inflammatory conditions. In contrast, the role of PPARgamma appears to be rather minor in keratinocytes, whereas its activity is required for sebaceous gland differentiation. Importantly, PPARalpha and beta/delta are instrumental in skin repair after an injury, each of them playing specific roles. Due to their collective diverse functions in skin biology, PPARs represent a major research target for the understanding and treatment of many skin diseases, such as benign epidermal tumors, papillomas, acne vulgaris and psoriasis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17400022     DOI: 10.1016/j.bbalip.2007.02.004

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  56 in total

1.  The relationship of diet and acne: A review.

Authors:  Apostolos Pappas
Journal:  Dermatoendocrinol       Date:  2009-09

2.  PPARγ-mediated and arachidonic acid-dependent signaling is involved in differentiation and lipid production of human sebocytes.

Authors:  Aniko Dozsa; Balazs Dezso; Balazs I Toth; Attila Bacsi; Szilard Poliska; Emanuela Camera; Mauro Picardo; Christos C Zouboulis; Tamás Bíró; Gerd Schmitz; Gerhard Liebisch; Ralph Rühl; Eva Remenyik; Laszlo Nagy
Journal:  J Invest Dermatol       Date:  2013-10-15       Impact factor: 8.551

3.  Hormones and the pilosebaceous unit.

Authors:  Wen-Chieh Chen; Christos C Zouboulis
Journal:  Dermatoendocrinol       Date:  2009-03

4.  DeltaNp63α protein triggers epithelial-mesenchymal transition and confers stem cell properties in normal human keratinocytes.

Authors:  Ju-Eun Oh; Reuben H Kim; Ki-Hyuk Shin; No-Hee Park; Mo K Kang
Journal:  J Biol Chem       Date:  2011-08-31       Impact factor: 5.157

Review 5.  Neuroprotective mechanisms of peroxisome proliferator-activated receptor agonists in Alzheimer's disease.

Authors:  Rupinder K Sodhi; Nirmal Singh; Amteshwar S Jaggi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-05-24       Impact factor: 3.000

6.  Activators of PPARs and LXR decrease the adverse effects of exogenous glucocorticoids on the epidermis.

Authors:  Marianne Demerjian; Eung-Ho Choi; Mao-Qiang Man; Sandra Chang; Peter M Elias; Kenneth R Feingold
Journal:  Exp Dermatol       Date:  2009-02-19       Impact factor: 3.960

7.  Role of peroxisome proliferator-activated receptor-α on the synthesis of monounsaturated fatty acids in goat mammary epithelial cells.

Authors:  Huibin Tian; Jun Luo; Hengbo Shi; Xiaoying Chen; Jiao Wu; Yusheng Liang; Cong Li; Juan J Loor
Journal:  J Anim Sci       Date:  2020-03-01       Impact factor: 3.159

8.  The peroxisome proliferator-activated receptor gamma system regulates ultraviolet B-induced prostaglandin e(2) production in human epidermal keratinocytes.

Authors:  Raymond L Konger; Kellie Clay Martel; Danielle Jernigan; Qiwei Zhang; Jeffrey B Travers
Journal:  PPAR Res       Date:  2010-05-19       Impact factor: 4.964

9.  Activation of PPARbeta/delta causes a psoriasis-like skin disease in vivo.

Authors:  Malgorzata Romanowska; Louise Reilly; Colin N A Palmer; Mattias C U Gustafsson; John Foerster
Journal:  PLoS One       Date:  2010-03-16       Impact factor: 3.240

10.  PPARbeta activation inhibits melanoma cell proliferation involving repression of the Wilms' tumour suppressor WT1.

Authors:  Jean-François Michiels; Christophe Perrin; Nathalie Leccia; Daniela Massi; Paul Grimaldi; Nicole Wagner
Journal:  Pflugers Arch       Date:  2010-01-12       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.